Averitas is dedicated to advancing pre-clinical and clinical research in its therapeutic areas, particularly chronic neuropathic pain conditions, and improving outcomes for patients. Recognizing pain as a disease in need of innovative solutions, Averitas actively supports ethical, independent clinical and non-clinical research conducted by qualified third-party investigators as part of its mission.
The proposed research must present meaningful scientific objectives supported by a robust and valid study design. The privacy rights, safety, and welfare of both patients and animals must be thoroughly safeguarded.
While Averitas recognizes the important work that your proposal is intended to fund, please note that Averitas has limited funding available and regrets that not all requests can be fulfilled. Prior to submitting an application, please consider the following:
Applications from organizations and individuals primarily focused on peripheral neuropathic pain will be given priority, aligning with our current disease state focus. Funding determinations are made solely based on the scientific merit of the proposals and their alignment with our initiatives. No consideration is given to past, present, or future business relationships with the recipient individuals or organizations. Specifically, recipients’ prescribing habits, formulary status, reimbursement activities, or recommendations of Averitas products are not taken into account.
